Intent to Award Sole Source Contract-BPA areawide Ortho Clinical Diagnostics Inc; Ortho Vision Swift Auto Blood Bank Analyzer & Workstation IDS-MATS Gel Card w/Equip Reagent Controls Consumables Srv & Support f/IHS Great Plains Area hospitals & clinics
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Great Plains Area Indian Health Service (GPAIHS), Aberdeen, SD, has issued a Notice of Intent to Award a Sole Source Contract to Ortho-Clinical Diagnostics, Inc. for an area-wide Blanket Purchase Order Agreement (BPA). This BPA will cover Ortho Vision Swift Automated Blood Bank Analyzers & Workstation IDS-MATS Gel Cards, including equipment, reagents, controls, consumables, service, and support for GPA IHS hospitals and clinics. Responses challenging the sole source intent are due by February 19, 2026.
Scope of Work
This requirement is for the purchase of instruments, reagents, controls, and consumables, along with a comprehensive service and support agreement. The BPA will support all hospitals and clinics within the Great Plains Area Indian Health Service (GPA IHS) that utilize the Ortho Vision Swift Automated Blood Bank Analyzer & Ortho Workstation IDS-MATS Gel Card Equipment.
Contract & Timeline
- Type: Sole Source Intent for a Firm Fixed-Price, Area-wide Blanket Purchase Order Agreement (BPA).
- Intended Awardee: Ortho-Clinical Diagnostics, Inc. (large business).
- Duration: Ordering period not exceeding five (5) years or sixty (60) months.
- Anticipated Award Date: March 15, 2025.
- Response Due: February 19, 2026, at 6:00 PM ET.
- Published: February 4, 2026.
- Estimated Value: Below the simplified acquisition threshold.
Justification for Sole Source
The sole source action is pursued under FAR 6.302-1, citing that Ortho-Clinical Diagnostics, Inc. is the sole manufacturer of the specified analyzers and related supplies, which are exclusively designed for their instruments. They are also the only authorized service provider in the U.S. Market research, including a sources sought notice, did not yield any responsible competitive responses.
Additional Notes
This is not a request for quotes or proposals. Interested parties must submit clear and convincing evidence demonstrating that competition would be advantageous to the Government, not cost or time prohibitive, and would not hinder the agency's mission objective. The Government retains discretion on whether to conduct a competitive procurement.
Contact: Ursula Maslonka, Contract Specialist, at Ursula.Maslonka@ihs.gov. Subject line must include "Notice of Intent IHS151945-IHS1512223, Ortho-Clinical Diagnostics, Inc."